Please login to the form below

Not currently logged in
Email:
Password:

Lynn Lewis joins Envigo

She becomes the CRO’s senior vice president of global sales

EnvigoEnvigo, a contract research organisation, has appointed Lynn Lewis to the position of senior vice president of global sales, a new role created to strengthen the company’s position in the marketplace with a focus on customer service.

For the past 15 years Lewis worked for Covance, most recently as its group vice president of business development, clinical development and commercialisation services.

Her career has also seen her work for Eli Lilly leading cross-functional development teams bringing new medicines to market.

Dr Adrian Hardy, president and chief executive officer of Envigo, said: “We are thrilled Lynn Lewis has joined our team to drive this important effort.

“Lynn’s broad experience leading billion dollar, successful global sales organisations serving the biopharmaceutical industry will be an invaluable asset to our commercial team.”

Lewis’ new role will see her lead sales teams in North America, Europe and Asia Pacific, providing a focus on growth initiatives and enhancing customer experience.

28th February 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics